Loughborough University
Browse

Toward acellular xenogeneic heart valve prostheses: histological and biomechanical characterization of decellularized and enzymatically deglycosylated porcine pulmonary heart valve matrices

Download (4.18 MB)
journal contribution
posted on 2021-01-26, 12:53 authored by Katja Findeisen, Lucrezia Morticelli, Tobias Goecke, Louisa Kolbeck, Robert Ramm, Hans-Klaus Höffler, Gudrun Brandes, Sotiris KorossisSotiris Korossis, Axel Haverich, Andres Hilfiker
The use of decellularized xenogeneic heart valves might offer a solution to overcome the issue of human valve shortage. The aim of this study was to revise decellularization protocols in combination with enzymatic deglycosylation, in order to reduce the immunogenicity of porcine pulmonary heart valves, in means of cells, carbohydrates, and, primarily, Galα1-3Gal (α-Gal) epitope removal. In particular, the valves were decellularized with sodium dodecylsulfate/sodium deoxycholate (SDS/SD), Triton X-100 + SDS (Tx + SDS), or Trypsin + Triton X-100 (Tryp + Tx) followed by enzymatic digestion with PNGaseF, Endoglycosidase H, or O-glycosidase combined with Neuraminidase. Results showed that decellularization alone reduced carbohydrate structures only to a limited extent, and it did not result in an α-Gal free scaffold. Nevertheless, decellularization with Tryp + Tx represented the most effective decellularization protocol in means of carbohydrates reduction. Overall, carbohydrates and α-Gal removal could strongly be improved by applying PNGaseF, in particular in combination with Tryp + Tx treatment, contrary to Endoglycosidase H and O-glycosidase treatments. Furthermore, decellularization with PNGaseF did not affect biomechanical stability, in comparison with decellularization alone, as shown by burst pressure and uniaxial tensile tests. In conclusion, valves decellularized with Tryp + Tx and PNGaseF resulted in prostheses with potentially reduced immunogenicity and maintained mechanical stability.

Funding

German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) via the Cluster of Excellence “From regenerative biology to reconstructive therapy” (REBIRTH) and via project C7 of TRR127 (Biology of xenogeneic cell and organ transplantation—from bench to bedside)

Cortiss foundation

History

School

  • Mechanical, Electrical and Manufacturing Engineering

Published in

Xenotransplantation

Volume

27

Issue

5

Publisher

Wiley

Version

  • VoR (Version of Record)

Rights holder

© The Authors

Publisher statement

This is an Open Access Article. It is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (CC BY-NC-ND 4.0). Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/

Acceptance date

2020-05-15

Publication date

2020-06-18

Copyright date

2020

ISSN

0908-665X

eISSN

1399-3089

Language

  • en

Depositor

Prof Sotiris Korossis. Deposit date: 21 January 2021

Article number

e12617

Usage metrics

    Loughborough Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC